what compound is cagrilintide | C194H312N54O59S2 | CID 171397054 Cagrilintide (10mg vials) - Peptide

But those are different trials with different durations and doses, and cagrilintides strongest data are as the CagriSema combination, so any ranking is a cross-trial inference rather than a proven result

Apply these five checks to the popular claim retatrutide is far better than cagrilintide and it quickly reduces to: a 48-week top-dose monotherapy number for one, next to a 26-week monotherapy number for the other whose real strength is a combination with no head-to-head trial anywhere in the chain

The defensible, peer-reviewed statement is: standalone cagrilintide produced about 10.8% at 26 weeks at 4.5 mg in Phase 2

A: Pramlintide requires multiple daily doses